*Correspondence: Shailendra Pratap Singh, [email protected] ORCID: sapna tiwari, orcid.org/0009-0000-5282-0324 Anjali Gupta, orcid.org/0009-0006-4759-9315 Deepa Pandey, orcid.org/0009-0005-0951-6761 Priyul Pandey, orcid.org/0009-0008-7084-2824 Rinkesh Gupta, orcid.org/0009-0006-9779-3618 Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
If you're losing weight too rapidly or feeling weak, consult your healthcare provider
Biomedicines 11:206

Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity - Diabetes, Obesity and Metabolism GLP-1RA Essentials in Gastroenterology: Side Effect Management, Precautions for Endoscopy and Applications for Gastrointestinal Disease Treatment - MDPI Gastroenterology Insights Mechanisms underlying the prokinetic effects of endogenous glucagon-like peptide-1 in the rat proximal colon - American Journal of Physiology - Gastrointestinal and Liver Physiology Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes - new England Journal of Medicine Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis - Diabetes Technology & Therapeutics Gastrointestinal tolerability of onceweekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss - Diabetes, Obesity and Metabolism GLP-1RAs caused gastrointestinal adverse reactions of drug withdrawal: a system review and network meta-analysis - Frontiers in Endocrinology Occurrence of Gastrointestinal Adverse Events Upon GLP-1 Receptor Agonist Initiation With Concomitant Metformin Use: A Post Hoc Analysis of LEADER, STEP 2, SUSTAIN-6, and PIONEER 6 - American Diabetes Association, Diabetes Care Glucagon-Like Peptide-1 Receptor Agonists - StatPearls

Add water slowly down the inner wall of the vial never directly onto the powder to avoid foaming and protein denaturation